Vimian Group publishes Annual Report for 2022

Regulatory press release
May 03 2023

Vimian Group publishes Annual Report for 2022

Vimian Group has published its Annual Report for 2022. The Annual Report also includes Vimian Group’s Sustainability Report.

Other receivables and other current liabilities on the consolidated balance sheet differ from the fourth quarter financial report as these were updated to reflect the settlement agreement in the US patent dispute reached on 4 April 2023.

Vimian Group’s Annual Report including Sustainability Report for 2022 can be found here: https://vimian.com/investors/reports-and-presentations/

About Vimian

Vimian is a global animal health company covering four essential and rapidly evolving areas: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services. At Vimian, we believe that every animal deserves the best available care. We bring pioneering and entrepreneurial businesses together to make the market’s most innovative offerings accessible to more animal health professionals and pet owners. Headquartered in Stockholm, Sweden, Vimian reaches over 15,000 veterinary clinics and 1,700 labs, sells to over 90 markets, employs close to 900 people and has annual turnover of approximately EUR 280 million. For more information, please visit: www.vimian.com. FNCA Sweden AB is appointed the Company’s Certified Adviser.